‘Emerging Treatment Strategies for Motor Fluctuation Management: Therapeutic Options for Newly Detected Motor Fluctuations’ reviews a series of posters on the topic of Parkinson’s disease (PD) presented at the 7th Congress of the European Academy of Neurology (EAN) 2021. Posters presented included real-world data on the efficacy and safety of emerging treatments for patients with PD, with a focus on opicapone (ONGENTYS®, Bial, Trofa, Portugal), a catechol-O-methyltransferase inhibitor developed to manage motor fluctuations, symptoms that severely impact patient quality of life.
Latest articles
All articles
7 Mins
13th
March
Does the Gut Microbiome Influence the Efficacy of Psychiatric Drugs?
Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified specific…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
5 Mins
13th
March
Systemic Health Impact of Leaky Barriers in the Oral-Gut-Brain Axis
The human body is a holistic system, interconnected by the circulatory, nervous, lymphatic, endocrine, and immune systems that facilitate…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
5 Mins
13th
March
Infliximab-Induced Multifocal Motor Neuropathy
Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder characterised by progressive, asymmetric muscle weakness…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
8 Mins
16th
January
Long-Term Patient Outcomes: The Role of Sustained Treatment Efficacy in Myasthenia Gravis
There have been great advances in the field of generalised myasthenia gravis (gMG) in recent years, but many patients remain dissatisfied…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.